These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25252305)

  • 1. [Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs)].
    Ren C; Sun H; Wang L; Zhang G; Fan Y; Yan G; Wang D; Wang F
    Yi Chuan; 2014 Sep; 36(9):879-87. PubMed ID: 25252305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
    Heng BC; Fussenegger M
    Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.
    Choi HW; Kim JH; Chung MK; Hong YJ; Jang HS; Seo BJ; Jung TH; Kim JS; Chung HM; Byun SJ; Han SG; Seo HG; Do JT
    Stem Cells Dev; 2015 Jun; 24(11):1366-73. PubMed ID: 25590788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells.
    Park SJ; Lee SA; Prasain N; Bae D; Kang H; Ha T; Kim JS; Hong KS; Mantel C; Moon SH; Broxmeyer HE; Lee MR
    Stem Cells Dev; 2017 May; 26(10):734-742. PubMed ID: 28346802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic Cell Reprogramming: A New Technology for Basic Research and Applied Usage].
    Bogomazova AN; Vassina EM; Kiselev SI; Lagarkova MA; Lebedeva OS; Nekrasov ED; Panova AV; Philonenko ES; Khomyakova EA; Tskhovrebova LV; Chestkov IV; Shutova MV
    Genetika; 2015 Apr; 51(4):466-78. PubMed ID: 26087622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress made in the reprogramming field: new factors, new strategies and a new outlook.
    Hussein SM; Nagy AA
    Curr Opin Genet Dev; 2012 Oct; 22(5):435-43. PubMed ID: 22959308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of genomic imprinting by reprogramming and redifferentiation.
    Kim MJ; Choi HW; Jang HJ; Chung HM; Arauzo-Bravo MJ; Schöler HR; Do JT
    J Cell Sci; 2013 Jun; 126(Pt 11):2516-24. PubMed ID: 23525019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current progress and potential practical application for human pluripotent stem cells.
    Philonenko ES; Shutova MV; Chestkov IV; Lagarkova MA; Kiselev SL
    Int Rev Cell Mol Biol; 2011; 292():153-96. PubMed ID: 22078961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced pluripotent stem cells in medicine and biology.
    Takahashi K; Yamanaka S
    Development; 2013 Jun; 140(12):2457-61. PubMed ID: 23715538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.
    Tao Y; Zheng W; Jiang Y; Ding G; Hou X; Tang Y; Li Y; Gao S; Chang G; Zhang X; Liu W; Kou X; Wang H; Jiang C; Gao S
    BMC Biol; 2014 Dec; 12():109. PubMed ID: 25528259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
    Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
    Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells.
    Ji J; Sharma V; Qi S; Guarch ME; Zhao P; Luo Z; Fan W; Wang Y; Mbabaali F; Neculai D; Esteban MA; McPherson JD; Batada NN
    Stem Cell Reports; 2014 Jan; 2(1):44-51. PubMed ID: 24511469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.
    Yoshihara M; Hayashizaki Y; Murakawa Y
    Stem Cell Rev Rep; 2017 Feb; 13(1):7-16. PubMed ID: 27592701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NuRD blocks reprogramming of mouse somatic cells into pluripotent stem cells.
    Luo M; Ling T; Xie W; Sun H; Zhou Y; Zhu Q; Shen M; Zong L; Lyu G; Zhao Y; Ye T; Gu J; Tao W; Lu Z; Grummt I
    Stem Cells; 2013 Jul; 31(7):1278-86. PubMed ID: 23533168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genomic stability of induced pluripotent stem cells.
    Chen Z; Zhao T; Xu Y
    Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.
    Kang L; Kou Z; Zhang Y; Gao S
    J Genet Genomics; 2010 Jul; 37(7):415-21. PubMed ID: 20659705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.